Arterial Stents

Arterial Stents

Global Arterial Stents Market to Reach US$25.2 Billion by 2030

The global market for Arterial Stents estimated at US$14.5 Billion in the year 2023, is expected to reach US$25.2 Billion by 2030, growing at a CAGR of 8.2% over the analysis period 2023-2030. Coronary Stents, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$12.8 Billion by the end of the analysis period. Growth in the Peripheral Stents segment is estimated at 8.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.8 Billion While China is Forecast to Grow at 12.0% CAGR

The Arterial Stents market in the U.S. is estimated at US$3.8 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$6.3 Billion by the year 2030 trailing a CAGR of 12.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.2% and 7.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.0% CAGR.

Global Arterial Stents Market - Key Trends & Drivers Summarized

Why Are Arterial Stents Crucial for Managing Cardiovascular Diseases?

Arterial stents have become an essential medical device in the treatment of cardiovascular diseases, particularly in patients suffering from coronary artery disease (CAD) or peripheral artery disease (PAD). These small, tube-like devices are used to open up blocked or narrowed arteries, ensuring proper blood flow to the heart and other critical organs. With cardiovascular diseases remaining the leading cause of death worldwide, arterial stents play a vital role in reducing complications such as heart attacks, strokes, and limb ischemia. The growing incidence of lifestyle-related health conditions, including obesity, diabetes, and hypertension, has further driven the demand for arterial stents, making them a key component of modern cardiovascular care.

How Are Technological Advances Revolutionizing Arterial Stent Design?

The development of drug-eluting stents (DES) and bioresorbable stents represents a significant technological advancement in the arterial stent market. Drug-eluting stents release medications over time to prevent restenosis, the re-narrowing of the artery, which has improved patient outcomes by reducing the need for repeat interventions. Bioresorbable stents, which gradually dissolve after fulfilling their purpose, offer a promising solution for reducing long-term complications associated with traditional metal stents. Furthermore, advances in imaging technology, such as optical coherence tomography (OCT) and intravascular ultrasound (IVUS), have improved the precision with which stents are deployed, enhancing the success of stenting procedures. These innovations are transforming the stent market by offering safer, more effective solutions for managing complex cardiovascular conditions.

What Regulatory Standards Are Shaping the Arterial Stents Market?

Regulatory standards play a crucial role in the arterial stents market, as the safety and efficacy of these medical devices must be carefully evaluated before they can be used in patients. Agencies such as the FDA and European Medicines Agency (EMA) require that stents undergo rigorous clinical testing to ensure they meet stringent quality and safety standards. This includes demonstrating the stent`s ability to maintain arterial patency without causing adverse effects such as blood clotting or inflammation. Post-market surveillance is also essential, as it allows regulatory bodies to monitor long-term patient outcomes and identify any emerging risks associated with new stent technologies. Compliance with these standards is vital for manufacturers to gain approval and build trust with healthcare providers and patients.

What Factors Are Driving the Growth of the Arterial Stents Market?

The growth in the arterial stents market is driven by several factors, including the rising prevalence of cardiovascular diseases, technological advancements in stent design, and the increasing demand for minimally invasive procedures. The global burden of heart disease and stroke is prompting greater demand for stent-based interventions, particularly as healthcare systems shift toward preventive care and early diagnosis. Technological innovations such as drug-eluting and bioresorbable stents are improving patient outcomes, leading to increased adoption in both developed and emerging markets. The growing preference for minimally invasive procedures, which offer quicker recovery times and reduced complications, is further boosting the use of arterial stents. Additionally, the expansion of healthcare infrastructure in developing countries is opening new opportunities for market growth as access to advanced cardiovascular care increases.

Select Competitors (Total 46 Featured) -

• Abbott Laboratories
• B. Braun Melsungen AG
• BARD, A Becton, Dickinson Company
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Cook Group, Inc.
• Medtronic PLC
• MicroPort Scientific Corporation
• Stentys SA
• Terumo Corporation

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.